---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-036607"
form_type: "8-K/A"
ticker: "CYPH"
cik: "0001509745"
company_name: "CYPHERPUNK TECHNOLOGIES INC."
filed_at: "2023-03-24T23:59:59+00:00"
generated_at: "2026-06-17T16:32:40.435420+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Leap Therapeutics removes requirement to file Flame Biosciences financials

## Summary
- Amendment to 8-K (filed Jan 23, 2023) deletes references to filing financial statements and pro forma info for Flame Biosciences acquisition.
- Company determined financial statements for the January 2023 acquisition are not required under Item 9.01 of Form 8-K.
- No change to acquisition terms or closing date; procedural update only.

## SEC filing metadata
- accession: 0001104659-23-036607
- form_type: 8-K/A
- ticker: CYPH
- cik: 0001509745
- company_name: CYPHERPUNK TECHNOLOGIES INC.
- filed_at: 2023-03-24T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1509745/000110465923036607/0001104659-23-036607-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1509745/000110465923036607/tm2310372d2_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-036607
- JSON: https://secwatch.observer/filing/0001104659-23-036607.json
- Plain text: https://secwatch.observer/filing/0001104659-23-036607.txt

## Key facts
- M&A Transactions
  CYPHERPUNK TECHNOLOGIES INC. completed an acquisition involving Flame Biosciences, Inc. (closed 2023-01-23).
  - Action: acquisition
  - Counterparty: Flame Biosciences, Inc.
  - Closing: 2023-01-23
  source text: On January 23, 2023, Leap Therapeutics, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Form 8-K”) disclosing the Company’s acquisition of Flame Biosciences, Inc., a Delaware corporation, pursuant to an Agreement and Plan of Merger, dated January 17, 2023 (the “Acquisition”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1509745/000110465923036607/0001104659-23-036607-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.